Detalhe da pesquisa
1.
Therapeutic evaluation of immunomodulators in reducing surgical wound infection.
FASEB J
; 36(1): e22090, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34907595
2.
Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study.
J Chem Inf Model
; 61(11): 5469-5483, 2021 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34666487
3.
Radiotherapy-assisted tumor selective metronomic oral chemotherapy.
Int J Cancer
; 141(9): 1912-1920, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28635011
4.
Chemical Conjugate of Low Molecular Weight Heparin and Suramin Fragment Inhibits Tumor Growth Possibly by Blocking VEGF165.
Mol Pharm
; 12(11): 3935-42, 2015 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26448404
5.
Absorption Mechanism of a Physical Complex of Monomeric Insulin and Deoxycholyl-l-lysyl-methylester in the Small Intestine.
Mol Pharm
; 12(6): 1911-20, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25892399
6.
Reduced Bioactive Microbial Products (Pathogen-Associated Molecular Patterns) Contribute to Dysregulated Immune Responses and Impaired Healing in Infected Wounds in Mice with Diabetes.
J Invest Dermatol
; 144(2): 387-397.e11, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37619833
7.
Colchicine-Binding Site Agent CH-2-77 as a Potent Tubulin Inhibitor Suppressing Triple-Negative Breast Cancer.
Mol Cancer Ther
; 21(7): 1103-1114, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35499388
8.
X-ray Crystallography-Guided Design, Antitumor Efficacy, and QSAR Analysis of Metabolically Stable Cyclopenta-Pyrimidinyl Dihydroquinoxalinone as a Potent Tubulin Polymerization Inhibitor.
J Med Chem
; 64(17): 13072-13095, 2021 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34406768
9.
Orally available tubulin inhibitor VERU-111 enhances antitumor efficacy in paclitaxel-resistant lung cancer.
Cancer Lett
; 495: 76-88, 2020 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32920198
10.
Metronomic oral doxorubicin in combination of Chk1 inhibitor MK-8776 for p53-deficient breast cancer treatment.
Biomaterials
; 182: 35-43, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30103170
11.
Oral pemetrexed facilitates low-dose metronomic therapy and enhances antitumor efficacy in lung cancer.
J Control Release
; 284: 160-170, 2018 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29908222
12.
A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway.
Biomaterials
; 139: 56-66, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28586719
13.
Metronomic chemotherapy using orally active carboplatin/deoxycholate complex to maintain drug concentration within a tolerable range for effective cancer management.
J Control Release
; 249: 42-52, 2017 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28093298
14.
Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate).
Biomaterials
; 86: 56-67, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26890038
15.
Functionalized heparin-protamine based self-assembled nanocomplex for efficient anti-angiogenic therapy.
J Control Release
; 197: 180-9, 2015 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25445701
16.
Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acid.
Biomaterials
; 35(24): 6543-52, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24816287